Parameter
| Biomarker | S-TK1 | Full name | Serum thymidine kinase 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis, disease status assessment |
| Disease | Non-Hodgkin Lymphoma (NHL) | Disease Subtypes | / | ||
| Organ | Blood and lymphoid tissue | Test Sample / Technology Platform | Serum (Novel antibody detection method) | ||
| Pathobiological Mechanisms | Participates in DNA synthesis, with elevated levels during tumor cell proliferation and higher baseline levels compared to healthy controls. | ||||
| Clinical Availability Status | Research phase: Limited sample size and short follow-up period, reliability of conclusions remains to be validated. | ||||
| Notes and Dynamics | Larger-scale studies are required to confirm its value as a diagnostic and prognostic biomarker. | ||||